Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Ovarian
- Status
- UNKNOWN
- Phase
- PHASE2
Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells)
- Status
- TERMINATED
- Phase
- PHASE1
CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
CBA Versus FBA Conditioning Followed by Haploidentical Allogeneic HSCT in Treatment of High Risk and Refractory AML
- Status
- UNKNOWN
- Phase
- PHASE3
CBA Versus FBA Conditioning Followed by Allogeneic HSCT in Treatment of High Risk and Refractory AML
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple Myeloma
- Status
- UNKNOWN
- Phase
- NA
Safety and Efficacy Evaluation of IM19 Cells
- Status
- UNKNOWN
- Phase
- PHASE1
Thiotepa Plus Fludarabine+ Melphalan as the Preparative Regime for Alternative Donor Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Crenolanib With Fludarabine and Cytarabine in Pediatric Patients With Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of BCMA CAR-T in Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study to Evaluate the Safety and Efficacy of KITE-585 in Participants With Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors
- Status
- UNKNOWN
- Phase
- NA
TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Epigenetic Reprogramming in Relapse/Refractory AML
- Status
- COMPLETED
- Phase
- PHASE1
Post Transplant Cyclophosphamide (PTCY) as Sole Graft Versus Host Disease (GVHD) Prophylaxis for Matched Allotransplant: CYRIC
- Status
- TERMINATED
- Phase
- PHASE2